Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)

(2015) Stephen F. Weng et al.   ATHEROSCLEROSIS

Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales

(2015) K. Haralambos et al.   ATHEROSCLEROSIS

Prevalence and treatment of familial hypercholesterolaemia in Australian communities

(2015) Gerald F. Watts et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia

(2014) Jacques Genest et al.   CANADIAN JOURNAL OF CARDIOLOGY

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

(2014) M. Cuchel et al.   EUROPEAN HEART JOURNAL

Corrigendum

(2014)   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

(2014) Ron Do et al.   NATURE

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

(2013) Gerald F. Watts et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Discriminative Ability of LDL-Cholesterol to Identify Patients With Familial Hypercholesterolemia

(2012) Roeland Huijgen et al.   Circulation-Cardiovascular Genetics

Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29 365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants

(2012) Roeland Huijgen et al.   EUROPEAN HEART JOURNAL

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

(2012) Marianne Benn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Familial hypercholesterolaemia: A model of care for Australasia

(2011) Gerald F. Watts et al.   ATHEROSCLEROSIS SUPPLEMENTS

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway

(2009) D. M. Oosterveer et al.   EUROPEAN HEART JOURNAL

Comparison of Genetic Versus Clinical Diagnosis in Familial Hypercholesterolemia

(2008) Fernando Civeira et al.   AMERICAN JOURNAL OF CARDIOLOGY

Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease

(2008) Jeppe Zacho et al.   NEW ENGLAND JOURNAL OF MEDICINE